Are you a skilled scientist with a desire to take the next step in your career?
We are recruiting a Senior Scientist- Development to join our Development group within Pharma Services. As an experienced hire, the right candidate will be /have:
The Senior Scientist is a key role within the Development team at Broughton, working on varied and complex products from both the Pharmaceutical and Animal Health Industries. In this role, you will regularly collaborate with a wide range of industry-leading companies from around the world. You will understand the complexities of their products, develop and validate analytical methods to allow routine product release in our QC department or transfer to their manufacturing facilities. The internal and external teams will benefit from your integrated working style and recognise the value of your scientific development expertise.
The typical activities executed by the successful applicant are:
Broughton provides exciting opportunities for you to apply your knowledge, skills and experience through hands-on assignments and projects. You will work alongside the best Analysts and Scientists in industry. Each year, Broughton invests in learning and development offering you a competitive salary, pension, supportive leadership team and tailored training programme. Join our team to discover your potential and take pride in valuable achievements.
Broughton Laboratories is a privately-owned global analytical services business. We are an FDA and MHRA inspected laboratory focused on delivering a high-quality service for industry-leading clients across the pharmaceutical, animal health, medical device and electronic nicotine delivery industries. Whether its innovation or optimisation, Broughton Laboratories tackles the toughest challenges from new product development to fast-paced routine quality control.
Please fill in the form below, and attach your CV, cover letter and salary requirements to be considered for the Senior Scientist - Development role. Closing Date for applications is December 31, 2018.